Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-DoseCytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis

Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-DoseCytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis / Ferreri Andres, J. M.; Reni, Michele; Foppoli, Marco; Marteili, Maurizio; Siakantaris, Marina; Frezzato, Maurizio; Cabras Maria, Giuseppina; Fabbri, Alberto; Corazzelli, Gaetano; Ilariucci, Fiorella; Rossi, Giuseppe; Soffietti, Riccardo; Stelitano, Caterina; Vallisa, Daniele; Zaja, Francesco; Gelemur, Marta; Aondio Gian, Marco; Avvisati, Giuseppe; Balzarotti, Monica; Brandes, Alba; Costa Maria, Joao; Gomez, Henry; Guarini, Attilio; Pinotti, Graziella; Rigacci, Luigi; Uhlmann, Catrina; Angelopoulou, Maria; Tirindelli, Maria; Naso, Virginia; Franzin, Alberto; Anzalone, NICOLETTA EMANUELA; Ponzoni, Maurilio; Zucca, Emanuele; Caligaris Cappio, Federico; Cavalli, Franco. - In: BLOOD. - ISSN 0006-4971. - 112:11(2008), pp. 218-218.